HRP20090116T3 - Non-steroidal compounds useful as glucocorticoid receptor modulators - Google Patents

Non-steroidal compounds useful as glucocorticoid receptor modulators

Info

Publication number
HRP20090116T3
HRP20090116T3 HR20090116T HRP20090116T HRP20090116T3 HR P20090116 T3 HRP20090116 T3 HR P20090116T3 HR 20090116 T HR20090116 T HR 20090116T HR P20090116 T HRP20090116 T HR P20090116T HR P20090116 T3 HRP20090116 T3 HR P20090116T3
Authority
HR
Croatia
Prior art keywords
alkyl
halogen
optionally substituted
hetero
aryl
Prior art date
Application number
HR20090116T
Other languages
English (en)
Croatian (hr)
Inventor
Plate Ralf
Gerardus Johannes Maria Jans Christiaan
Original Assignee
N.V. Organon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by N.V. Organon filed Critical N.V. Organon
Publication of HRP20090116T3 publication Critical patent/HRP20090116T3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Otolaryngology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HR20090116T 2005-08-29 2006-08-25 Non-steroidal compounds useful as glucocorticoid receptor modulators HRP20090116T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05107896 2005-08-29
PCT/EP2006/065696 WO2007025938A1 (en) 2005-08-29 2006-08-25 Non-steroidal compounds useful as glucocorticoid receptor modulators

Publications (1)

Publication Number Publication Date
HRP20090116T3 true HRP20090116T3 (en) 2009-04-30

Family

ID=35466054

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20090116T HRP20090116T3 (en) 2005-08-29 2006-08-25 Non-steroidal compounds useful as glucocorticoid receptor modulators

Country Status (30)

Country Link
US (1) US8575152B2 (de)
EP (1) EP1924580B1 (de)
JP (1) JP5191383B2 (de)
KR (1) KR20080040024A (de)
CN (1) CN101304999B (de)
AR (1) AR058027A1 (de)
AT (1) ATE421516T1 (de)
AU (1) AU2006286524B2 (de)
BR (1) BRPI0615412A2 (de)
CA (1) CA2621229A1 (de)
CY (1) CY1109041T1 (de)
DE (1) DE602006005006D1 (de)
DK (1) DK1924580T3 (de)
EC (1) ECSP088289A (de)
ES (1) ES2320273T3 (de)
HR (1) HRP20090116T3 (de)
IL (1) IL189463A (de)
MY (1) MY145591A (de)
NO (1) NO20080940L (de)
NZ (1) NZ566005A (de)
PE (1) PE20070331A1 (de)
PL (1) PL1924580T3 (de)
PT (1) PT1924580E (de)
RS (1) RS50763B (de)
RU (1) RU2420528C2 (de)
SI (1) SI1924580T1 (de)
TW (1) TWI375676B (de)
UA (1) UA92024C2 (de)
WO (1) WO2007025938A1 (de)
ZA (1) ZA200801599B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103130717B (zh) * 2011-11-29 2015-04-01 上海博康精细化工有限公司 二苯并氮卓酮的制备方法
WO2025255469A1 (en) * 2024-06-06 2025-12-11 Psammiad Therapeutics, Inc. Compounds and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3657250A (en) * 1970-02-10 1972-04-18 Ayerst Mckenna & Harrison Benzocycloheptaisoquinoline derivatives
IL36085A (en) * 1970-02-10 1974-09-10 Ayerst Mckenna & Harrison Octahydrobenzo(6,7)cyclohepta(1,2,3-d,a)pyrido(or pyrrolo)-(2,1-a)isoquinolines and decahydrobenzo-(6,7)cyclohepta-(1,2,3-d,e)azepino(2,1-a)isoquinolines and their preparation
NL7305811A (de) * 1973-04-26 1974-10-29
US4016161A (en) * 1974-04-24 1977-04-05 Akzona Incorporated Amino-substituted 1,2,3,4,10,146-hexahydro-pyridino[1,2-a]dibenzo[c,f]azepines
EP1043325B1 (de) * 1994-12-22 2004-06-16 Ligand Pharmaceuticals Incorporated Steroidrezeptor-Modulator Verbindungen und Methoden
IL146057A (en) * 2000-10-27 2007-09-20 Pfizer Prod Inc A process for the preparation of modulators of a non-steroidal glucocorticoid receptor
TWI297685B (en) * 2002-04-04 2008-06-11 Organon Nv Non-steroidal progesterone receptor modulators
EP1534273A4 (de) 2002-07-18 2007-08-22 Bristol Myers Squibb Co Modulatoren des glucocorticoid-rezeptors und verfahren

Also Published As

Publication number Publication date
UA92024C2 (ru) 2010-09-27
RU2008112206A (ru) 2009-10-10
NZ566005A (en) 2010-01-29
PL1924580T3 (pl) 2009-07-31
CN101304999A (zh) 2008-11-12
RU2420528C2 (ru) 2011-06-10
AU2006286524B2 (en) 2011-06-16
EP1924580B1 (de) 2009-01-21
DK1924580T3 (da) 2009-05-11
BRPI0615412A2 (pt) 2012-12-04
CA2621229A1 (en) 2007-03-08
ECSP088289A (es) 2008-04-28
KR20080040024A (ko) 2008-05-07
US8575152B2 (en) 2013-11-05
CN101304999B (zh) 2011-11-16
ES2320273T3 (es) 2009-05-20
TWI375676B (en) 2012-11-01
AU2006286524A1 (en) 2007-03-08
AR058027A1 (es) 2008-01-23
PE20070331A1 (es) 2007-04-16
NO20080940L (no) 2008-05-05
WO2007025938A1 (en) 2007-03-08
RS50763B (sr) 2010-08-31
DE602006005006D1 (de) 2009-03-12
ATE421516T1 (de) 2009-02-15
JP2009506093A (ja) 2009-02-12
IL189463A0 (en) 2008-06-05
US20080188459A1 (en) 2008-08-07
SI1924580T1 (sl) 2009-06-30
PT1924580E (pt) 2009-04-01
TW200745105A (en) 2007-12-16
MY145591A (en) 2012-02-29
IL189463A (en) 2011-07-31
CY1109041T1 (el) 2014-07-02
EP1924580A1 (de) 2008-05-28
JP5191383B2 (ja) 2013-05-08
ZA200801599B (en) 2009-01-28

Similar Documents

Publication Publication Date Title
AR051469A1 (es) Derivados de indol tetraciclicos como agentes antiviricos
NO20022683L (no) Ureaforbindelser med muskarinisk reseptor-antagonistaktivitet
AR038536A1 (es) N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
CY1114908T1 (el) Παραγωγα κινολινης ως αντιβακτηριακοι παραγοντες
ATE482945T1 (de) Heterozyklische indolderivate und mono- oder diazaindol-derivate
DE602004031258D1 (de) Polycyclische mittel zur behandlung von infektione
HRP20090250T1 (hr) Kondenzirani heterociklički spojevi i njihova upotreba kao inhibitora hcv polimeraze
CO6231028A2 (es) Compuestos y composiciones como inhibidores de la proteina quinasa
HRP20020317B1 (en) Pharmaceutically active compounds
PE20060837A1 (es) COMPUESTOS DE 3H-OXAZOLO Y 3H-TIAZOLO[4,5-d]PIRIMIDIN-2-ONA 3,5-DISUSTITUIDA Y 3,5,7-TRISUSTITUIDA Y PROFARMACOS DE LOS MISMOS
CO6140056A2 (es) Compuestos amino -5-4(difluorometoxi)fenil sustituido-5-fenilimidazolona como inhibidores de beta -secretasa
AU2000265939A1 (en) Novel pseudoerythromycin derivatives
AR051958A1 (es) Derivados heterociclicos utiles como moduladores selectivos del receptor de androgeno (sarms)
EP1643984A4 (de) Verwendung von parthenolid-derivaten als antileukämische und zytotoxische mittel
ATE461192T1 (de) Chinoloncarbonsäureverbindungen mit 5-ht4- rezeptoragonistischer wirkung
AR050208A1 (es) Compuesto de heteroaril sulfonamida sustituida, procedimiento para la preparacion del mismo, composicion farmaceutica que lo comprende y su uso para preparar un medicamento
HUP0004477A2 (hu) Herbicid hatású 3-(1,2-benzizotiazol- vagy-izoxazol-5-il)-csoporttal helyettesített pirimidinszármazékok, intermedierjeik, előállításuk és alkalmazásuk
ATE286031T1 (de) Substituierte 5-benzyl-2,4-diaminopyrimidine
ATE556712T1 (de) A2a antagonisten zur behandlung von motorischen störungen
DK1847534T3 (da) Thiadiazolin-derivater til behandling af kræft
HRP20090116T3 (en) Non-steroidal compounds useful as glucocorticoid receptor modulators
AR068381A1 (es) Compuestos de quinolina apropiados para tratar trastornos que responden a la modulacion del receptor de serotonina 5-ht6
HRP20090161T1 (hr) Nesteroidni modulatori glukokortikoidnog receptora
ATE195517T1 (de) Chinolinonderivate und diese enthaltende antiallergische zusammensetzungen
FI933815A0 (fi) Nya 3-oxadiazolyl-1,6-naftyridinderivat